{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:20:12Z","timestamp":1792819212151,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2023YFF0716000, 2024YFC2419800"],"award-info":[{"award-number":["2023YFF0716000, 2024YFC2419800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472013"],"award-info":[{"award-number":["82472013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07490-x","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T03:11:32Z","timestamp":1755227492000},"page":"1041-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive analysis of [18F]MFBG biodistribution normal patterns and variability in pediatric patients with neuroblastoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Peipei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-3982","authenticated-orcid":false,"given":"Xinhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"27","key":"7490_CR1","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","volume":"33","author":"NR Pinto","year":"2015","unstructured":"Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33(27):3008\u201317.","journal-title":"J Clin Oncol"},{"key":"7490_CR2","doi-asserted-by":"crossref","unstructured":"Matthay KK, Maris JM, Schleiermacher G et al. Neuroblastoma Nat Rev Dis Primers. 2016;216078\u201399.","DOI":"10.1038\/nrdp.2016.78"},{"issue":"11","key":"7490_CR3","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","volume":"45","author":"Z Bar-Sever","year":"2018","unstructured":"Bar-Sever Z, Biassoni L, Shulkin B, et al. Guidelines on nuclear medicine imaging in neuroblastoma. Eur J Nucl Med Mol Imaging. 2018;45(11):2009\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"7490_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pbc.21932","volume":"52","author":"TA Vik","year":"2009","unstructured":"Vik TA, Pfluger T, Kadota R, et al. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial. Pediatr Blood Cancer. 2009;52(7):784\u201390.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"7490_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.semnuclmed.2016.10.007","volume":"47","author":"T Pfluger","year":"2017","unstructured":"Pfluger T, Piccardo A, Neuroblastoma. MIBG imaging and new tracers. Semin Nucl Med. 2017;47(2):143\u201357.","journal-title":"Semin Nucl Med"},{"issue":"12","key":"7490_CR6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","volume":"37","author":"E Bombardieri","year":"2010","unstructured":"Bombardieri E, Giammarile F, Aktolun C, et al. 131I\/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010;37(12):2436\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7490_CR7","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1158\/1078-0432.CCR-13-1153","volume":"20","author":"H Zhang","year":"2014","unstructured":"Zhang H, Huang R, Cheung NK, et al. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res. 2014;20(8):2182\u201391.","journal-title":"Clin Cancer Res"},{"key":"7490_CR8","doi-asserted-by":"crossref","unstructured":"Samim A, Tytgat GAM, Bleeker G et al. Nuclear medicine imaging in neuroblastoma: current status and new developments. J Pers Med. 2021;11(4):270\u201382.","DOI":"10.3390\/jpm11040270"},{"issue":"1","key":"7490_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/RLU.0000000000004447","volume":"48","author":"P Wang","year":"2023","unstructured":"Wang P, Li T, Cui Y, et al. 18 F-MFBG PET\/CT is an effective alternative of 68 Ga-DOTATATE PET\/CT in the evaluation of metastatic pheochromocytoma and paraganglioma. Clin Nucl Med. 2023;48(1):43\u20138.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"7490_CR10","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s00259-023-06221-4","volume":"50","author":"P Wang","year":"2023","unstructured":"Wang P, Li T, Liu Z, et al. [(18)F]MFBG PET\/CT outperforming [(123)I]MIBG SPECT\/CT in the evaluation of neuroblastoma. Eur J Nucl Med Mol Imaging. 2023;50(10):3097\u2013106.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7490_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00259-013-2558-9","volume":"41","author":"H Zhang","year":"2014","unstructured":"Zhang H, Huang R, Pillarsetty N, et al. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter. Eur J Nucl Med Mol Imaging. 2014;41(2):322\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7490_CR12","doi-asserted-by":"publisher","unstructured":"Chen X, Wang G, Yang S, et al. Increased uptake of [(18)F]MFBG in a patient with potential MEN2 syndrome. Eur J Nucl Med Mol Imaging. 2024;52(7):2247\u201348. https:\/\/doi.org\/10.1007\/s00259-024-07005-0.","DOI":"10.1007\/s00259-024-07005-0"},{"issue":"5","key":"7490_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/RLU.0000000000003997","volume":"47","author":"P Wang","year":"2022","unstructured":"Wang P, Hou G, Jing H, et al. Similar findings on 18F-MFBG PET\/CT and 68Ga-DOTATATE PET\/CT in a patient with widespread metastatic pheochromocytoma. Clin Nucl Med. 2022;47(5):451\u20133.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"7490_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/RLU.0000000000005224","volume":"49","author":"P Wang","year":"2024","unstructured":"Wang P, Li T, Zhuang H, et al. 18 F-MFBG PET\/CT and MRI in identifying brain metastases in a posttreatment neuroblastoma patient. Clin Nucl Med. 2024;49(6):600\u20133.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"7490_CR15","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00259-023-06160-0","volume":"50","author":"L Borgwardt","year":"2023","unstructured":"Borgwardt L, Brok JS, Andersen KF, et al. (18)F]mFBG long axial field of view PET-CT without general anaesthesia reveals concise extension of neuroblastoma in a 9-month-old boy. Eur J Nucl Med Mol Imaging. 2023;50(8):2563\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7490_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00259-020-04830-x","volume":"48","author":"E Pauwels","year":"2021","unstructured":"Pauwels E, Celen S, Vandamme M, et al. Improved resolution and sensitivity of [(18)F]MFBG PET compared with [(123)I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour. Eur J Nucl Med Mol Imaging. 2021;48(1):313\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"7490_CR17","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00259-025-07098-1","volume":"52","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Deng X, Song S, et al. Leveraging small voxel with optimal acquisition time for [(18)F]mFBG total-body PET\/CT imaging in pediatric patients with neuroblastoma: a preliminary study. Eur J Nucl Med Mol Imaging. 2025;52(7):2397\u2013413.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"7490_CR18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s00259-022-06046-7","volume":"50","author":"E Pauwels","year":"2023","unstructured":"Pauwels E, Celen S, Baete K, et al. (18)F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [(123)I] MIBG in neural crest tumour patients. Eur J Nucl Med Mol Imaging. 2023;50(4):1134\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"7490_CR19","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s00259-022-06063-6","volume":"50","author":"A Samim","year":"2023","unstructured":"Samim A, Blom T, Poot AJ, et al. [(18)F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study. Eur J Nucl Med Mol Imaging. 2023;50(4):1146\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7490_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2967\/jnumed.117.193169","volume":"59","author":"N Pandit-Taskar","year":"2018","unstructured":"Pandit-Taskar N, Zanzonico P, Staton KD, et al. Biodistribution and dosimetry of (18)F-meta-fluorobenzylguanidine: a first-in-human PET\/CT imaging study of patients with neuroendocrine malignancies. J Nucl Med. 2018;59(1):147\u201353.","journal-title":"J Nucl Med"},{"key":"7490_CR21","doi-asserted-by":"crossref","unstructured":"Samim A, Suurd DPD, van Rooij R et al. SUV normalisation and reference tissue selection for [(1)8F]mFBG PET-CT in paediatric and adult patients. Eur J Nucl Med Mol Imaging. 2025;52(10):3773\u201380.","DOI":"10.1007\/s00259-025-07242-x"},{"issue":"1","key":"7490_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77788-3","volume":"10","author":"S Turnock","year":"2020","unstructured":"Turnock S, Turton DR, Martins CD, et al. (18)f-meta-fluorobenzylguanidine ((18)F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models. Sci Rep. 2020;10(1): 20918.","journal-title":"Sci Rep"},{"issue":"5","key":"7490_CR23","volume":"5","author":"J Wasserthal","year":"2023","unstructured":"Wasserthal J, Breit HC, Meyer MT, et al. Totalsegmentator: robust segmentation of 104 anatomic structures in CT images. Radiology: Artificial Intelligence. 2023;5(5): e230024.","journal-title":"Radiology: Artificial Intelligence"},{"issue":"2","key":"7490_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF, et al. The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol. 2009;27(2):298\u2013303.","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"7490_CR25","doi-asserted-by":"publisher","first-page":"s39","DOI":"10.2967\/jnumed.116.186833","volume":"58","author":"N Pandit-Taskar","year":"2017","unstructured":"Pandit-Taskar N, Modak S. Norepinephrine transporter as a target for imaging and therapy. J Nucl Med. 2017;58(Suppl 2):s39-53.","journal-title":"J Nucl Med"},{"issue":"8","key":"7490_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2967\/jnumed.123.267256","volume":"65","author":"L Borgwardt","year":"2024","unstructured":"Borgwardt L, Brok J, Andersen KF, et al. Performing [(18)F]MFBG long-axial-field-of-view PET\/CT without sedation or general anesthesia for imaging of children with neuroblastoma. J Nucl Med. 2024;65(8):1286\u201392.","journal-title":"J Nucl Med"},{"issue":"2","key":"7490_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/RLU.0000000000003389","volume":"46","author":"W Wang","year":"2021","unstructured":"Wang W, Yang X, Yang J. Elevated 123I-MIBG activity in intramuscular hemangioma. Clin Nucl Med. 2021;46(2):168\u201370.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"7490_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/RLU.0000000000003782","volume":"47","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang X, Wang W, Yang J. MIBG uptake in pancreas as a normal variant. Clin Nucl Med. 2022;47(2):168\u201371.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"7490_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/RLU.0000000000002598","volume":"44","author":"X Bai","year":"2019","unstructured":"Bai X, Wang X, Zhuang H. Increased gastric MIBG activity as a normal variant. Clin Nucl Med. 2019;44(9):761\u20133.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"7490_CR30","first-page":"803","volume":"35","author":"F Bonnin","year":"1994","unstructured":"Bonnin F, Lumbroso J, Tenenbaum F, et al. Refining interpretation of MIBG scans in children. J Nucl Med. 1994;35(5):803\u201310.","journal-title":"J Nucl Med"},{"issue":"2","key":"7490_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/02841859909177744","volume":"40","author":"H Jacobsson","year":"1999","unstructured":"Jacobsson H, Johansson L, Kimiaei S, Larsson SA. Concentration of 123I-metaiodobenzylguanidine in left and right liver lobes. Findings indicate regional differences in function in the normal liver. Acta Radiol. 1999;40(2):224\u20138.","journal-title":"Acta Radiol"},{"issue":"1","key":"7490_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.rlu.0000249592.95945.e4","volume":"32","author":"H Jacobsson","year":"2007","unstructured":"Jacobsson H, Hellstr\u00f6m PM, Kogner P, Larsson SA. Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth? Clin Nucl Med. 2007;32(1):24\u20138.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"7490_CR33","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1097\/RLU.0000000000002449","volume":"44","author":"Y Matsusaka","year":"2019","unstructured":"Matsusaka Y, Nakahara T, Iwabuchi Y, et al. Focal 123I-MIBG uptake in the medial segment of the normal liver. Clin Nucl Med. 2019;44(3):e170\u20131.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"7490_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35(2):500\u201316.","journal-title":"Radiographics"},{"issue":"5","key":"7490_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/RLU.0000000000005808","volume":"50","author":"H Dai","year":"2025","unstructured":"Dai H, Li X, Su M, Huang R. Increased 68Ga-DOTATATE uptake in brown adipose tissue in a case of head and neck paraganglioma. Clin Nucl Med. 2025;50(5):456\u20137.","journal-title":"Clin Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07490-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:06Z","timestamp":1769222766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07490-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7490"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07490-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking Union Medical College Hospital (Date: 27-Jul-2021\/No: ZS-2514) and the First Affiliated Hospital of Zhejiang University School of Medicine (Date: 10-Jan-2025\/No: [2025\u00a0C] IIT No.008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the guardians of the patient. In addition, when patients were over the age of 8, consent from the patients was also obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research patients provided informed consent for publication of the images in Figs.\u00a01, 2, 3, 4 and 5, and 6.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}